Clinical Trials Directory

Trials / Unknown

UnknownNCT04347694

Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.

COVID-19 Serology in Nephrology Health Care Workers

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

Infections with Corona-Viruses have shown to be a menace for patients with comorbidities such as hypertension, diabetes, cardiovascular disease or immunosuppression. Those are features almost every nephrological patient brings along, especially those on maintenance dialysis and those with renal transplant. Since the emergence of the novel coronavirus SARS-CoV-2 in November 2019 in Mainland China the fear for pandemic infections has increased. But not only is the course of infection itself important, the prevention of transmission to and by attending medical personnel should be put into perspective. Thus there is a lack of sufficient data of occult immunization or persistent state on immunization. In our study up to 400 health care personnel will be screened serologically for IgM, IgA and IgG against the SARS-CoV-2 virus. Blood and urine samples throughout 12 months will be sampled and analyzed. The aim of the study is to identify the rate of occult immunization and at the same time to gather data about the persistence of immune response to an infection with SARS-CoV-02. The results will help provide sufficient safety measures for health care providers and renal patients undergoing unavoidable clinical treatment.

Conditions

Timeline

Start date
2020-04-11
Primary completion
2021-04-11
Completion
2021-04-11
First posted
2020-04-15
Last updated
2020-09-02

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04347694. Inclusion in this directory is not an endorsement.